The Anti-Non-Small Cell Lung Cancer Cell Activity by a mTOR Kinase Inhibitor PQR620

In non-small-cell lung carcinoma (NSCLC), aberrant activation of mammalian target of rapamycin (mTOR) contributes to tumorigenesis and cancer progression. PQR620 is a novel and highly-potent mTOR kinase inhibitor. We here tested its potential activity in NSCLC cells. In primary human NSCLC cells and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zha, Jian-hua, Xia, Ying-chen, Ye, Chun-lin, Hu, Zhi, Zhang, Qin, Xiao, Han, Yu, Ben-tong, Xu, Wei-hua, Xu, Guo-qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222575/
https://www.ncbi.nlm.nih.gov/pubmed/34178653
http://dx.doi.org/10.3389/fonc.2021.669518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222575/
https://www.ncbi.nlm.nih.gov/pubmed/34178653
http://dx.doi.org/10.3389/fonc.2021.669518

Ejemplares similares